Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 26 Apr 2023
The dreaded hay fever signs, including itchy eyes, sneezing, and a stuffy nose, have arrived for many people with the arrival of spring. Up to 42% of people experience hay fever, making it a widespread condition. Immune system overreaction is the cause of it.
Read Full NewsA nurse practitioner-led outreach program improves the rates of breast and cervical cancer screening among women veterans in rural areas, a retrospective study shows.
Over half of patients in a randomized trial switch from enzalutamide to darolutamide because of cognitive issues; no one switches in the opposite direction.
1.
How Do Younger People Fare With Stool Tests for CRC Screening?
2.
In Higher-Risk MDS, CMML, All-Oral Therapy Has Promise.
3.
How breast tissue density affects your risk of breast cancer
4.
A Texas study found that the majority of pancreatic cancer patients do not receive life-saving surgery.
5.
SBRT May Beat Brachytherapy in Prostate Cancer
1.
Lu-177 Vipivotide in Prostate Cancer: A Breakthrough in Radioligand Therapy
2.
How Digital Innovation and AI-Powered Case Studies are Revolutionizing Oncology Education?
3.
Unveiling the Mystery Behind Castleman Disease – Understanding Its Causes and Symptoms
4.
Unpacking Chordoma: Understanding the Rare Cancer and its Treatment Options
5.
What You Need To Know About Trametinib: A Miracle Cancer Treatment?
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Newer Immunotherapies for Myeloma- A Comprehensive Overview
2.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part IV
3.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part V
4.
A Conclusive Discussion on CROWN Trial and the Dawn of a New Era in Frontline Management of ALK+ NSCLC
5.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion III
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge